Arcus kidney cancer drug data published in Nature journal
Go back to Arcus kidney cancer drug data published in Nature journal| (NYSE: RCUS) | Delayed: 29.06 -0.6 (2.02%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $29.66 | 52 Week High | $ | |||
| Open | $29.21 | 52 Week Low | $ | |||
| Day High | $29.50 | P/E | N/A | |||
| Day Low | $28.79 | EPS | $ | |||
| Volume | 1,363,510 | |||||
